Go to Content

EXORPHIA,Inc.
Development of EV-Containing Medium that Significantly Increases the Success Rate of In Vitro Fertilization

As of March,2025

City Year of Establishment Founder
Tokyo 2019 Koji KUCHIISHI
Partner VC Latest round of Fundraising Valuation
Coral Capital Non-Disclosure Non-Disclosure

  • Contact Information: 81-3-6824-0550
  • info@exorphia.com
  • Website:EXORPHIA,Inc.

Program name

Deep-Tech Startups Support Program

Research theme

Development of EV-Containing Medium that Significantly Increases the Success Rate of In Vitro Fertilization

Business Plan

Utilizing our high-quality EV (extracellular vesicles, exosomes) technology, an EV-containing culture media (additives) that will dramatically improve the success rate of in vitro fertilization shall be developed. The development results will also be applied to infertility drugs (outside of the NEDO project) to provide a comprehensive solution for couples suffering from infertility.

Phase Business Area/Field Research Period Research Grant Amount
STS Healthcare 2024~2026FY JPY 161 million

Last Updated : May 22, 2025